Coverage of buccal soft tissue dehiscences around implants with an acellular dermal matrix and apical buccal access. Randomized clinical trial

Oral Reconstruction Foundation0 sites28 target enrollmentJuly 20, 2021

Overview

Phase: 未知
Intervention: Not specified
Conditions: Buccal soft tissue dehiscences (recessions) around dental implants
Sponsor: Oral Reconstruction Foundation
Enrollment: 28
Status: Completed
Last Updated: last year

No summary available.

Registry

who.int

Start Date

July 20, 2021

End Date

June 10, 2024

Last Updated

last year

Study Type

Interventional

Sex

All

Sponsor

•1\. Age \=18 years
•2\. Periodontally and systemically healthy
•3\. Full\-mouth plaque score and full\-mouth bleeding score \= 20% (measured at four sites per tooth)
•4\. Correct implant 3\-dimensional position or buccal position \= 1 mm
•5\. Buccal soft tissue dehiscence \=4 mm
•6\. Only osseointegrated implants
•7\. The patient must be able to perform good oral hygiene

•1\. Contraindications for periodontal surgery
•2\. Patients pregnant or attempting to get pregnant
•3\. Malpositioned implant
•4\. Soft tissue dehiscence (STD) \>4 mm
•5\. Existing of peri\-implantitis
•6\. Severe bone loss (\=4mm)
•7\. Moderate\-severe interproximal bone loss (implant fixture level to the alveolar bone \>3 mm)
•8\. Moderate\-severe papilla height loss (Nordland and Tarnow implant papillae index \>1\)
•9\. Previous mucogingival surgery around the implant within the past six months or implant placement at the surgical site less than six months prior
•10\. Smoking more than 10 cigarettes a day